We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Antibodies Interpreted after Scrub Typhus Infection

By LabMedica International staff writers
Posted on 25 Jun 2018
Print article
Image: Orientia tsutsugamushi (arrows) in culture of bronchoalveolar lavage fluid from a patient with acute respiratory distress syndrome (Photo courtesy of Aix Marseille Université).
Image: Orientia tsutsugamushi (arrows) in culture of bronchoalveolar lavage fluid from a patient with acute respiratory distress syndrome (Photo courtesy of Aix Marseille Université).
Scrub typhus is a zoonotic infection caused by the bacterium Orientia tsutsugamushi. It is transmitted to humans by the bite of the larval stage of trombiculid mites. With an annual incidence of about one million cases, it is an important challenge to public health in Southeast Asia.

The clinical presentation may vary from a mild febrile illness to a life-threatening disseminated infection with serious complications such as acute respiratory distress syndrome, hepatitis, renal failure, meningitis, and multiple organ failure, making the diagnosis difficult. The serological detection of IgM antibodies is the most widely used test to diagnose scrub typhus infection.

Scientists at the Christian Medical College (Vellore, India) included in this cross-sectional study, 203 patients over 18 years of age with previously confirmed scrub typhus. Scrub typhus was confirmed by positive immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA) (optical density (OD) >0.8) and/or a positive polymerase chain reaction (PCR) for O. tsutsugamushi at a tertiary care teaching hospital in South India between December 2011 and March 2015.

The team performed ELISAs for IgM and IgG antibodies using the Scrub Typhus Detect kit (InBios International, Inc, Seattle, WA, USA). All patients had a positive IgM ELISA at diagnosis, of which 80 were confirmed by PCR. All patients had a blood sampling done during the study. Among them, eight patients had two blood samples taken at different time points. The time interval between confirmation of the original infection and study sample collection ranged from one month to 46 months. The overall trend showed a gradual fall in mean IgM levels over time, remaining above the threshold of positivity (OD >0.8) until 12 months after infection. The mean IgG levels showed a gradual rise, reaching a peak at 10 months post-infection, followed by a gradual decline, remaining above the cut-off threshold for more than 36 months.

The authors concluded that clinicians needed to be cautious in using a single serum sample for the detection of IgM to diagnose scrub typhus, as it remains elevated for up to 12 months after the infection, whereas the serum IgG level could be used as an indicator of past infection. The study was published in the June 2018 issue of the International Journal of Infectious Diseases.

Related Links:
Christian Medical College
InBios International
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.